Glucose/Sodium Chloride Fresenius Kabi (Sodium Chloride, Glucose Monohydrate)

Glucose/Sodium Chloride injection is used in clinical settings to address fluid and electrolyte deficits and to provide an energy source during intravenous therapy.

• Replenishment of extracellular fluid volume in patients with dehydration or hypovolemia.
• Replacement of sodium and chloride losses associated with gastrointestinal drainage, burns, or diuretic therapy.
• Provision of a carbohydrate source for patients unable to receive oral nutrition.
• Support of perioperative fluid management to maintain hemodynamic stability.
• Adjunctive therapy in parenteral nutrition regimens where glucose is required.

Adverse reactions to Glucose/Sodium Chloride injection are generally infrequent, but they may occur and are categorized by frequency and severity.

Common

• Mild local irritation at the infusion site.
• Transient hyperglycemia.
• Slight increase in serum sodium levels.
• Nausea or mild headache.

Serious

• Severe hypernatremia leading to neurologic symptoms.
• Anaphylactic or severe allergic reaction.
• Fluid overload causing pulmonary edema.

When administering Glucose/Sodium Chloride injection, clinicians should observe several precautions to minimize risk and ensure appropriate use.

• Assess patient’s fluid status and electrolyte balance before initiation.
• Monitor serum glucose and sodium concentrations during therapy.
• Use caution in patients with renal impairment or congestive heart failure.
• Adjust infusion rate in individuals at risk for rapid shifts in osmolarity.
• Avoid administration to patients with known hypersensitivity to any component of the solution.
• Consider compatibility with other intravenous medications before co‑infusion.

Glucose/Sodium Chloride injection may interact with other drugs; awareness of these interactions helps prevent adverse outcomes.

Avoid

• Concurrent administration with hypertonic saline solutions, which may cause excessive sodium load.
• Mixing with calcium‑containing solutions that can precipitate insoluble salts.

Use with caution

• Concurrent use of insulin or oral hypoglycemic agents, which may amplify glucose‑lowering effects.
• Diuretics that promote sodium loss, requiring close monitoring of electrolyte status.
• Blood pressure–lowering agents, as rapid volume expansion may affect hemodynamics.